Europe
-
Baricitinib could reduce COVID-19 mortality
Baricitinib, the rheumatoid arthritis drug, has shown promise as a treatment that could help to reduce COVID-19 mortality, an early-stage study has found. Read more
-
Some over 70s benefit from Vitamin D and Omega-3
Taking vitamin D and omega-3 yields health benefits for some older people, according to a study published yesterday (11 November 2020). Read more
-
Ethnicity affects COVID stroke risk – while statins may protect
The COVID-19 virus seems to double the risk of stroke for people of Asian descent, British researchers reported today. Read more
-
Synthetic nanobody could fight SARS-CoV-2 virus
A synthetic nanobody could be used to help combat COVID-19, a new study has revealed. Read more
-
Seven kinds of COVID disease?
Researchers in Austria have outlined seven distinct forms of disease in COVID-19 infection. Read more
-
Shop workers’ risk of getting COVID-19
Customer-facing shop staff are about five times more likely to test positive for COVID-19 than their colleagues in other positions, a small American study has found. Read more
-
Hope for new psoriasis treatment
A possible new therapy for psoriasis has shown promise, a European conference has heard. Read more
-
Air pollution link to some COVID-19 deaths
About 15% of COVID-19 deaths globally could be attributed to long-term exposure to air pollution, a new study claims today. Read more
-
New generation BRAF inhibitor shows promise
A drug designed to work against a range of BRAF mutations in several cancers is showing early promise, a European conference heard last night. Read more
-
Blood groups linked to COVID-19 risk
Two new studies have explored how blood groups are associated with risk of infection and severity of disease from SARS-CoV-2 infection. Read more